#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Albright's disease Chronic lymphocytic leukaemia recurrent Myelin oligodendrocyte glycoprotein antibody-associated disease Netherton's syndrome Cholangiosarcoma Cutaneous T-cell lymphoma stage I Rhabdomyosarcoma recurrent Hyperchylomicronaemia Osteosarcoma recurrent Central nervous system lymphoma Cataract High-grade B-cell lymphoma Congenital cystic kidney disease Haemophilia B with anti factor IX Neuroblastoma recurrent More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII – Diagnostics Chondrosarcoma metastatic Congenital nephrogenic diabetes insipidus – Trials in Disease Netherton’s syndrome – Basic Information Glycogen storage disease type V – Basic Information Proteus syndrome – Trials in Disease Gaucher’s disease type I – Diagnostics Leiomyosarcoma recurrent – Basic Information Paroxysmal nocturnal haemoglobinuria – Trials in Disease Methylmalonic acidaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tocotrienol LY3841136 SODIUM Alxn2220 Potassium Iodide Alirocumab POLYSORBATE 80 Zidesamtinib Levamisole Hydrochloride Ranolazine Bi 764532 Mycophenolic Acid Triptorelin Acetate Propranolol Hydrochloride Atomoxetine Hydrochloride Regn7075 PHENTOLAMINE MESILATE Estradiol Hemihydrate Cefepime Ecoo75 Triamcinolone Hexacetonide More therapies…

    Learn about Your Condition

    Glaucoma Adenosquamous cell lung cancer Renal transplant Autoimmune disorder Kawasaki's disease Pain Ewing's sarcoma metastatic BK virus infection Immune-mediated myositis Meningorrhagia Rhabdoid tumour of the kidney Oxygen therapy HER2 positive gastric cancer Pancreatic carcinoma stage IV Double hit lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on Sildenafil and Hypothermia for Newborns with Hypoxic-Ischemic Encephalopathy

    Not yet recruiting

    4 1 1 1
    Investigated Drugs:
    • Sildenafil
    France

  • Study of Rituximab compared to placebo in patients with anti-MAG neuropathy who are likely to respond well to treatment

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Anti-myelin-associated glycoprotein associated polyneuropathy
    Investigated Drugs:
    • Rituximab
    • Sodium Chloride
    France

  • Study of BIIB115 in patients aged 15‑60 years with spinal muscular atrophy who are treatment‑naïve or previously treated with risdiplam

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • BIIB115
    Finland France Germany Ireland Italy Poland +1

  • Intravenous ferric carboxymaltose for drug‑resistant restless legs syndrome: a randomized delayed‑start trial in adults

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Ferric Carboxymaltose
    France

  • Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +15

  • Phase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Fenebrutinib
    • Teriflunomide
    Austria Bulgaria Denmark France Greece Italy +1
Previous Page
1 … 79 80 81 82 83 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!